Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- Check7 days agoChange DetectedA 403 Forbidden page is now displayed, replacing the study details and navigation. Viewers can no longer access the study record from this page.SummaryDifference17%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedFooter revision updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.0%

- Check49 days agoChange DetectedThe revision tag on the page changed from v3.6.4 to v3.6.5, signaling a newer release of the page or its underlying system. This is a metadata update and does not modify study content or user-visible features.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now displays a new revision tag: v3.6.4, replacing v3.6.3. This is a minor UI/system update and does not alter study content or data.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3 in the Study Record, reflecting a minor metadata update; no study content or eligibility criteria are changed.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects an updated version of the study record.SummaryDifference0.0%

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.